Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
PreveCeutical Medical ( (TSE:PREV) ) just unveiled an update.
PreveCeutical Medical Inc. has appointed Dr. Bryan Jones as an advisor to lead Sol-Gel Special Projects, effective January 31, 2025. Dr. Jones, with over 30 years of experience in drug development, is expected to advance the company’s Sol-Gel program aimed at delivering therapeutics from nose to brain, accelerating its development and potentially enhancing the company’s position in the health sciences sector.
More about PreveCeutical Medical
PreveCeutical Medical Inc. is a health sciences company that develops innovative preventive and curative therapies using organic and nature-identical products.
YTD Price Performance: -16.67%
Average Trading Volume: 123,390
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $11.25M
For a thorough assessment of PREV stock, go to TipRanks’ Stock Analysis page.